Comprehensive molecular cytogenetic analysis of mantle cell lymphoma.

被引：0
|
作者：
Leupolt, E
Bullinger, L
Bentz, M
Ott, G
Müller-Hermelink, HK
Barth, TFE
Möller, P
Lichter, P
Döhner, H
Stilgenbauer, S
机构：
[1] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany
[2] Univ Wurzburg, Dept Pathol, D-97070 Wurzburg, Germany
[3] Univ Ulm, Dept Pathol, D-89069 Ulm, Germany
[4] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2315
引用
收藏
页码：517A / 517A
页数：1
相关论文
共 50 条
  • [41] Natural history and clinical prognosis of in situ mantle cell lymphoma.
    Kubal, Timothy Edward
    Peker, Deniz
    Sagatys, Elizabeth
    Zhang, Ling
    Naghashpour, Mojdeh
    Moscinski, Lynn
    Sotomayor, Eduardo M.
    Sokol, Lubomir
    Bello, Celeste M.
    Cultrera, Jennifer L.
    Chervenick, Paul A.
    Shah, Bijal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Impact of rituximab on outcome of autologous transplantation for mantle cell lymphoma.
    Naing, A.
    Palmer, J.
    Tsai, N.
    Kogut, N.
    Popplewell, L.
    Rodriguez, R.
    Krishnan, A.
    Nakamura, R.
    Forman, S. J.
    Nademanee, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 435S - 435S
  • [44] p16 gene aberrations in mantle cell lymphoma.
    Cohen, PL
    James, CD
    Kurtin, PJ
    BLOOD, 1997, 90 (10) : 2187 - 2187
  • [45] Use of attenuated adenovirus as therapeutic agents for Mantle cell lymphoma.
    Medina, DJ
    Sheay, W
    Goodell, L
    Rabson, AB
    Strair, RK
    BLOOD, 2000, 96 (11) : 242B - 242B
  • [46] Mapping of 11q deletions in mantle cell lymphoma.
    Stilgenbauer, S
    Winkler, D
    Ott, G
    James, MR
    Döhner, K
    Müller-Hermelink, HK
    Bentz, M
    Lichter, P
    Döhner, H
    BLOOD, 1998, 92 (10) : 412A - 412A
  • [47] Activity of bortezomib in mantle cell lymphoma, diffuse large B cell, and small lymphocytic lymphoma.
    Fauble, Veena S.
    Lobocki, Catherine
    Eapen, Amy
    Terebelo, Howard R.
    BLOOD, 2006, 108 (11) : 252B - 252B
  • [48] Multiple Recurrent Chromosomal Breakpoints in Mantle Cell Lymphoma Revealed by a Combination of Molecular Cytogenetic Techniques
    Salaverria, Itziar
    Espinet, Blanca
    Carrio, Ana
    Costa, Dolors
    Astier, Laura
    Slotta-Huspenina, Julia
    Quintanilla-Martinez, Leticia
    Fend, Falko
    Sole, Francesc
    Colomer, Dolors
    Serrano, Sergio
    Miro, Rosa
    Bea, Silvia
    Campo, Elias
    GENES CHROMOSOMES & CANCER, 2008, 47 (12): : 1086 - 1097
  • [49] Molecular cytogenetic analyses of the mediastinal B cell line MedB-1 and primary mediastinal B cell lymphoma.
    Barth, TFE
    Rother, U
    Brüderlein, S
    Stilgenbauer, S
    Leupolt, E
    Siebert, R
    Joos, S
    Bentz, M
    Möller, P
    BLOOD, 2002, 100 (11) : 191B - 191B
  • [50] Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.
    Hoster, Eva
    Klapper, Wolfram
    Rosenwald, Andreas
    Bernd, Heinz-Wolfram
    Hartmann, Sylvia
    Loddenkemper, Christoph
    Barth, Thomas F. E.
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Kluin-Nelemans, Hanneke C.
    Hermine, Olivier
    Dreyling, Martin
    BLOOD, 2012, 120 (21)
12345